Could groundbreaking CAR-T cancer therapy trigger more cancer?
Car-T therapy, short for “chimeric antigen receptor T-cell”, is a cutting-edge treatment that reprogrammes a patient’s immune cells to fight their cancer.
In recent years, scientists have advanced cancer treatment through immunotherapy, including Car-T therapy. This method reprograms a patient's immune cells to target and destroy cancer cells. Despite its success in treating lymphomas, concerns arose when the FDA investigated potential links between Car-T therapy and new cancers in treated patients. This scrutiny reflects the therapy's groundbreaking impact and ongoing efforts to ensure its safety and effectiveness.
